Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
- PMID: 30389920
- PMCID: PMC6214982
- DOI: 10.1038/s41467-018-06916-5
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
Abstract
The availability of multiple datasets comprising genome-scale RNAi viability screens in hundreds of diverse cancer cell lines presents new opportunities for understanding cancer vulnerabilities. Integrated analyses of these data to assess differential dependency across genes and cell lines are challenging due to confounding factors such as batch effects and variable screen quality, as well as difficulty assessing gene dependency on an absolute scale. To address these issues, we incorporated cell line screen-quality parameters and hierarchical Bayesian inference into DEMETER2, an analytical framework for analyzing RNAi screens ( https://depmap.org/R2-D2 ). This model substantially improves estimates of gene dependency across a range of performance measures, including identification of gold-standard essential genes and agreement with CRISPR/Cas9-based viability screens. It also allows us to integrate information across three large RNAi screening datasets, providing a unified resource representing the most extensive compilation of cancer cell line genetic dependencies to date.
Conflict of interest statement
W.C.H. is a consultant for Thermo-Fisher, Paraxel, AjuIB, MPM Capital and KSQ Therapeutics and receives research funding from Deerfield Management. W.C.H. is a founder and has equity in KSQ Therapeutics. T.R.G. is a consultant to Foundation Medicine and GlaxoSmithKline, and is a shareholder of FORMA Therapeutics. D.E.R. receives research funding from members of the Functional Genomics Consortium (Abbvie, Jannsen, Merck, Vir), and is a director of Addgene, Inc. A.T. is a consultant for Tango Therapeutics. All remaining authors declare no competing interests.
Figures
Similar articles
-
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.Genome Biol. 2023 Aug 23;24(1):192. doi: 10.1186/s13059-023-03020-w. Genome Biol. 2023. PMID: 37612728 Free PMC article.
-
Inferring cancer dependencies on metabolic genes from large-scale genetic screens.BMC Biol. 2019 Apr 30;17(1):37. doi: 10.1186/s12915-019-0654-4. BMC Biol. 2019. PMID: 31039782 Free PMC article.
-
Defining a Cancer Dependency Map.Cell. 2017 Jul 27;170(3):564-576.e16. doi: 10.1016/j.cell.2017.06.010. Cell. 2017. PMID: 28753430 Free PMC article.
-
RNAi/CRISPR Screens: from a Pool to a Valid Hit.Trends Biotechnol. 2019 Jan;37(1):38-55. doi: 10.1016/j.tibtech.2018.08.002. Epub 2018 Aug 31. Trends Biotechnol. 2019. PMID: 30177380 Review.
-
RNA interference in mammals: behind the screen.Brief Funct Genomics. 2011 Jul;10(4):215-26. doi: 10.1093/bfgp/elr018. Brief Funct Genomics. 2011. PMID: 21791555 Review.
Cited by
-
In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications.Nat Commun. 2024 Aug 15;15(1):7039. doi: 10.1038/s41467-024-51380-z. Nat Commun. 2024. PMID: 39147755 Free PMC article.
-
Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines.Cancer Res. 2022 Jun 6;82(11):2171-2184. doi: 10.1158/0008-5472.CAN-21-2428. Cancer Res. 2022. PMID: 35395071 Free PMC article.
-
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor.J Med Chem. 2022 May 12;65(9):6513-6540. doi: 10.1021/acs.jmedchem.1c01756. Epub 2022 Apr 25. J Med Chem. 2022. PMID: 35468293 Free PMC article.
-
miR-AB, a miRNA-based shRNA viral toolkit for multicolor-barcoded multiplex RNAi at a single-cell level.EMBO Rep. 2022 Apr 5;23(4):e53691. doi: 10.15252/embr.202153691. Epub 2022 Feb 24. EMBO Rep. 2022. PMID: 35201651 Free PMC article.
-
ZetaSuite: computational analysis of two-dimensional high-throughput data from multi-target screens and single-cell transcriptomics.Genome Biol. 2022 Jul 25;23(1):162. doi: 10.1186/s13059-022-02729-4. Genome Biol. 2022. PMID: 35879727 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
